Astragaloside II alleviates cardiac hypertrophy by targeting aminoacylase-1: a novel mechanism via the β-catenin/transcription factor 4/ubiquitin C-terminal hydrolase L1 axis
Br J Pharmacol. 2026 Apr 1. doi: 10.1111/bph.70416. Online ahead of print. ABSTRACT BACKGROUND AND PURPOSE: Aminoacylase-1 (ACY1) pathway has emerged as a strategy for …